END STAGE RENAL DISEASE
Clinical trials for END STAGE RENAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE RENAL DISEASE trials appear
Sign up with your email to follow new studies for END STAGE RENAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test aims to balance infection and rejection risks in kidney transplants
Disease control TerminatedThis study looked at whether a blood test called ImmuKnow can help doctors better manage anti-rejection drugs in kidney transplant patients. The goal was to reduce infections while still preventing organ rejection. Only 4 patients were enrolled before the study was stopped early,…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Kidney transplant breakthrough? drug combo aims to reduce lifelong pills
Disease control TerminatedThis study tested a drug called siplizumab combined with donor bone marrow cells to help kidney transplant patients potentially stop taking anti-rejection drugs long-term. Only 4 people took part before the study was ended early. The goal was to find the best dose to safely allow…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for kidney patients with Hard-to-Match immune systems
Disease control TerminatedThis study tested two drugs, daratumumab and belatacept, in 5 highly sensitized dialysis patients waiting for a kidney transplant. The goal was to safely reduce the antibodies that make it very hard to find a compatible donor kidney. The trial was stopped early, but it aimed to h…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a simple drug make donated kidneys start working faster?
Disease control TerminatedThis study tested whether the drug heme arginate can help transplanted kidneys work right away, instead of being slow to start. It included 47 adults receiving a kidney from a deceased donor. Participants got either the drug or a salt water solution at transplant and 24 hours lat…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Study aims to predict diabetes risk from common transplant drug
Knowledge-focused TerminatedThis study looked at how the drug tacrolimus, often used after kidney transplants, affects blood sugar and insulin in people with kidney failure who are waiting for a transplant. Researchers wanted to find early signs of diabetes risk so doctors could adjust treatment. The study …
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Dialysis showdown: which type helps kidney patients live longer?
Knowledge-focused TerminatedThis study compared survival in people with end-stage kidney disease who were randomly assigned to either peritoneal dialysis or hemodialysis. The goal was to see which type of dialysis leads to longer life and fewer complications. The study was conducted in China and was termina…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Vantive Health LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC